New Risk • Jun 30
New major risk - Revenue and earnings growth Revenue has declined by 13% over the past year. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If revenues are declining, then it is difficult for the company to prevent its earnings from declining as well. A trend of falling revenue can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Revenue has declined by 13% over the past year. Market cap is less than US$10m (€911.7k market cap, or US$1.04m). Minor Risks Latest financial reports are more than 6 months old (reported June 2025 fiscal period end). Share price has been volatile over the past 3 months (13% average weekly change). New Risk • May 18
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (€1.08m market cap, or US$1.25m). Minor Risk Latest financial reports are more than 6 months old (reported June 2025 fiscal period end). Board Change • Apr 15
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 2 highly experienced directors. Independent Director Gregoire Cabri-Wiltzer was the last director to join the board, commencing their role in 2022. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Board Change • Jan 01
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 2 highly experienced directors. Independent Director Gregoire Cabri-Wiltzer was the last director to join the board, commencing their role in 2022. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. 공고 • Jul 16
Lucibel SA, Annual General Meeting, Jul 30, 2025 Lucibel SA, Annual General Meeting, Jul 30, 2025. Location: 165 rue du general de gaulle, le houlme France New Risk • Jul 02
New major risk - Negative shareholders equity The company has negative equity. Total equity: -€713k This is considered a major risk. Being in negative equity means that the company's liabilities exceed its assets, meaning it owes more to creditors than it has in owned assets. While this doesn't mean the company is about to collapse, in the long-term, this is unsustainable. The company may have issues meeting financial obligations, is at risk of becoming insolvent and may have difficulty raising capital, especially more debt, if needed. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (45% average weekly change). Negative equity (-€713k). Shareholders have been substantially diluted in the past year (34% increase in shares outstanding). Market cap is less than US$10m (€2.67m market cap, or US$3.15m). Reported Earnings • Jul 02
Full year 2024 earnings released: €0.14 loss per share (vs €0.004 profit in FY 2023) Full year 2024 results: €0.14 loss per share (down from €0.004 profit in FY 2023). Revenue: €6.34m (down 30% from FY 2023). Net loss: €3.15m (down €3.23m from profit in FY 2023). Over the last 3 years on average, earnings per share has increased by 36% per year but the company’s share price has fallen by 62% per year, which means it is significantly lagging earnings. New Risk • May 19
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (27% average weekly change). Shareholders have been substantially diluted in the past year (67% increase in shares outstanding). Market cap is less than US$10m (€3.04m market cap, or US$3.39m). Minor Risk Latest financial reports are more than 6 months old (reported June 2024 fiscal period end). New Risk • Apr 19
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 67% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (24% average weekly change). Shareholders have been substantially diluted in the past year (67% increase in shares outstanding). Market cap is less than US$10m (€2.67m market cap, or US$3.04m). 공고 • Mar 28
Lucibel SA announced that it expects to receive €0.850108 million in funding Lucibel SA announced a private placement that it will issue up to 8,501,082 shares at an issue price of €0.1 per share for the gross proceeds of up to €850,108.20 on March 27, 2025. 공고 • May 26
Lucibel SA, Annual General Meeting, Jun 27, 2024 Lucibel SA, Annual General Meeting, Jun 27, 2024. Location: 101 allee des vergers, barentin France Reported Earnings • Apr 17
Full year 2023 earnings released Full year 2023 results: Revenue: €9.04m (up 11% from FY 2022). Net income: €73.0k (up €2.36m from FY 2022). Profit margin: 0.8% (up from net loss in FY 2022). New Risk • Apr 11
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: €9.25m (US$9.91m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (€9.25m market cap, or US$9.91m). Minor Risks Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). Share price has been volatile over the past 3 months (8.5% average weekly change). Shareholders have been diluted in the past year (19% increase in shares outstanding). New Risk • Apr 07
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). Share price has been volatile over the past 3 months (9.7% average weekly change). Shareholders have been diluted in the past year (19% increase in shares outstanding). Market cap is less than US$100m (€9.59m market cap, or US$10.4m). New Risk • Feb 02
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: €9.00m (US$9.70m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-€1.6m free cash flow). Less than 1 year of cash runway based on free cash flow trend (-€1.6m free cash flow). Market cap is less than US$10m (€9.00m market cap, or US$9.70m). Minor Risks Share price has been volatile over the past 3 months (9.8% average weekly change). Shareholders have been diluted in the past year (19% increase in shares outstanding). Shareholders have been diluted in the past year (19% increase in shares outstanding). New Risk • Nov 30
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: €8.96m (US$9.77m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-€1.6m free cash flow). Market cap is less than US$10m (€8.96m market cap, or US$9.77m). Minor Risks Share price has been volatile over the past 3 months (8.0% average weekly change). Shareholders have been diluted in the past year (19% increase in shares outstanding). Reported Earnings • Sep 25
First half 2023 earnings released: EPS: €0.01 (vs €0.043 loss in 1H 2022) First half 2023 results: EPS: €0.01 (up from €0.043 loss in 1H 2022). Revenue: €5.01m (up 25% from 1H 2022). Net income: €179.0k (up €831.0k from 1H 2022). Profit margin: 3.6% (up from net loss in 1H 2022). Reported Earnings • Oct 12
First half 2022 earnings released: €0.04 loss per share (vs €0.096 loss in 1H 2021) First half 2022 results: €0.04 loss per share (improved from €0.096 loss in 1H 2021). Revenue: €4.01m (down 21% from 1H 2021). Net loss: €652.0k (loss narrowed 55% from 1H 2021). 공고 • Jul 23
Lucibel SA announced that it expects to receive €1.7 million in funding from Nice & Green SA Lucibel SA announced that it has entered into financing agreement to issue redeemable share subscription warrants for gross proceeds of €1.7 million on July 21, 2022. The transaction will include participation from Nice & Green SA. The financing program consists of 5 equal tranches of 300,000 redeemable share subscription warrants by issue of a maximum of 1,500,000 redeemable share subscription warrants. The unit subscription price of each redeemable share subscription warrants is equal to 20% of the volume-weighted average price of 10 trading sessions immediately preceding the date of subscription of a tranche of redeemable share subscription warrants and will be paid by investor to company on the subscription date. The issue subject to the approval of the AMF. Reported Earnings • Apr 13
Full year 2021 earnings released: €0.20 loss per share (vs €0.18 loss in FY 2020) Full year 2021 results: €0.20 loss per share (down from €0.18 loss in FY 2020). Revenue: €9.15m (down 10% from FY 2020). Net loss: €2.93m (loss widened 14% from FY 2020).